# Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

> **NCT07224581** · PHASE3 · RECRUITING · sponsor: **GRIN Therapeutics, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- GRIN-related Neurodevelopmental Disorder

## Interventions

- **DRUG:** Radiprodil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07224581
- **Lead sponsor:** GRIN Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2027-05
- **Final completion:** 2028-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224581, "Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07224581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*